C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
11/2004
11/30/2004	US6825212 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
11/30/2004	US6825187 Carbapenem derivatives substituted at the 2-position with a substituted imidazo(5,1-b)thiazole group; use against antibiotic resistant staphylococcus aureus and pseudomonas aeruginosa, enterococci and influenza virus
11/25/2004	WO2004021984A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235838 Use of 2-alkoxyphenol-substituted imidazotriazinones
11/24/2004	EP1480032A1 Reagent for determining the absolute configuration of chiral compound and determination method
11/24/2004	EP1479681A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE
11/24/2004	EP1478646A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
11/24/2004	EP1411949A4 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
11/24/2004	EP0960111B1 Morphine derivatives with analgesic activity
11/24/2004	CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
11/23/2004	US6821982 Preparation of a camptothecin derivative by intramolecular cyclisation
11/23/2004	US6821981 For therapy of disorders, such as anxiety, aggression and stress, and for the control of various physiological phenomena, such as appetite, thermoregulation, sleep and sexual behavior
11/23/2004	US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/18/2004	US20040229938 Reacting dihydroartemisin or dihydroartemistene with an appropriate optionally substituted 1, 2 or 1, 3 or 1, 4 glycol under acidic conditions such as borontrifluoride etherate followed by additional functionallization of the resulting dimer; anti-malarial and anti-leishmanial
11/18/2004	US20040229897 Aid in cytokine biosynthesis
11/18/2004	US20040229877 Administering pyrrolotriazine carboxamide and benzamide compounds for therapy of p38 kinase-associated conditions
11/18/2004	US20040229324 such as 5,6-dihydro-4H-pyrrolo(1,2-b)pyrazole-2-carboxylic acid; solvent extraction; for production of beta-lactamase inhibitors
11/17/2004	EP1476449A1 Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
11/17/2004	EP1084126B1 Novel vinca-alkaloid derivatives and preparation method
11/17/2004	EP0832092B1 Orally active adenosine kinase inhibitors
11/17/2004	CN1547472A Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
11/11/2004	WO2004096801A1 Cannabinoid receptor ligands and uses thereof
11/11/2004	WO2004096800A2 Quinuclidine derivatives binding to mucarinic m3 receptors
11/11/2004	WO2004078110A3 Fused imizadoles as transforming growth factor (tgf) inhibitors
11/11/2004	WO2004070364A8 Method for the determination of absolute configuration of chiral compounds
11/11/2004	WO2004056879A8 Spirotetrathiocarbamates and spirooxothiocarbamates
11/11/2004	WO2003097356A9 Camptothecin derivatives and polymeric conjugates thereof
11/11/2004	US20040224977 Racemic mixtures for treatment of diseases with alpha 7nicotinic acetyl chloline administering
11/11/2004	US20040224945 Novel substituted pyrazole derivatives
11/11/2004	CA2520842A1 Cannabinoid receptor ligands and uses thereof
11/10/2004	EP1475382A1 Compounds as semaphorin inhibitors
11/10/2004	EP1474471A1 Selective oxidation of sodium sulfide in kraft cooking liquors
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474420A1 Quinazoline compounds
11/10/2004	EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones
11/10/2004	EP1474148A1 Treatment of neuroblastoma
11/09/2004	US6815448 For therapy of ognitive deficits due to aging, stroke, head trauma, alzheimer's disease or other neurodegenerative diseases, or schizophrenia; anxiety, aggression and stress, and for the control of various physiological phenomena
11/09/2004	US6815444 Anti-enterovirus compounds
11/04/2004	WO2004094647A2 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	WO2004094432A1 Porphyrin compound containing biotinyl group and use thereof
11/04/2004	WO2004087145A3 Antibacterial agents
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220178 Substituted heterocycle fused gamma-carbolines
11/04/2004	CA2522700A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/03/2004	EP1472260A2 Thieno(3,2-b)pyridones as antiviral compounds
11/03/2004	EP1392697B1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f]quinoline
11/03/2004	EP1347974B1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
11/03/2004	EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004	CN1543465A Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof
11/02/2004	US6812234 Ccr-2; inflammatory, immunoregulatory, allergic, and autoimmune disorders and diseases
10/2004
10/28/2004	WO2004092181A1 Heterocyclic mchr1 antagonists
10/28/2004	WO2004092173A2 A2a adenosine receptor antagonists
10/28/2004	WO2004092172A2 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists
10/28/2004	WO2004092171A2 Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists
10/28/2004	WO2004092170A2 Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists
10/28/2004	WO2004092124A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
10/28/2004	WO2004091504A2 Substituted quinobenzoxazine analogs
10/28/2004	WO2004091485A2 Aminoquinoline compounds
10/28/2004	WO2004091482A2 M3 muscarinic acetylcholine receptor antagonists
10/28/2004	WO2004010512A3 Heteroatom-containing diamondoid transistors
10/28/2004	US20040214847 Anti-first-pass effect compounds
10/28/2004	US20040214837 such as 3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(4-methylpiperazin-1-yl)-2H-pyrazolo[4,3-d]pyrimidine; for treatment of eating disorders and psychological disorders
10/28/2004	CA2521832A1 Heterocyclic mchr1 antagonists
10/28/2004	CA2521810A1 Substituted quinobenzoxazine analogs
10/28/2004	CA2521619A1 Aminoquinoline compounds
10/27/2004	EP1470131A2 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
10/27/2004	EP1470125A1 Aminopiperidine derivatives
10/27/2004	EP1315728B1 Process for the preparation of vitronectin receptor antagonists
10/26/2004	US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
10/26/2004	US6809094 N-fused hetercyclo-1,4- or -1,5- diazabicyclo derivatives; nicotinic receptor agonists; central nervous system (cns)
10/21/2004	WO2004090046A1 Fluorescent diketopyrrolopyrroles
10/21/2004	WO2004058144A3 Antibacterial agents
10/21/2004	WO2004056879A3 Spirotetrathiocarbamates and spirooxothiocarbamates
10/21/2004	WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
10/21/2004	US20040209902 Aminoquinoline compounds
10/21/2004	US20040209897 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
10/21/2004	US20040209889 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
10/21/2004	US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
10/21/2004	US20040209864 Substituted heterocycle fused gamma-carbolines
10/20/2004	EP1468112A2 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
10/20/2004	EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
10/20/2004	CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease
10/20/2004	CN1537857A Compound, its preparation method and its application
10/20/2004	CN1537856A Anti-first-pass effect compounds
10/14/2004	WO2004087717A1 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines as potential antitumour agents and process thereof
10/14/2004	WO2004087716A1 Pyrrolo[(2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof
10/14/2004	WO2004087145A2 Antibacterial agents
10/14/2004	WO2004069256A8 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
10/14/2004	US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
10/14/2004	US20040204436 Imidazonaphthyridines
10/14/2004	US20040204416 Pharmaceutical composition for the treatment of CNS and other disorders
10/14/2004	US20040204400 Anti-enterovirus compounds
10/14/2004	US20040204397 Calcitonin gene related peptide receptor antagonists
10/13/2004	EP1466607A1 Compositions for the treatment of primary and metastatic neoplastic diseases using arsenic compounds in combination with all-trans retinoic acid
10/13/2004	EP1465899A1 Trioxane derivatives
10/13/2004	EP1465896A2 Mitotic kinesin inhibitors
10/13/2004	EP1465895A2 4-oxo-4,7-dihydrofuro(2,3-b)pyridine-5-carboxamide antiviral agents

1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 111